Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial.
Vaccines (Basel). 2023 Feb 1;11(2):326. doi: 10.3390/vaccines11020326.
Vaccines (Basel). 2023.
PMID: 36851204
Free PMC article.
SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study.
Vakhrusheva AV, Kudriavtsev AV, Kryuchkov NA, Deev RV, Frolova ME, Blagodatskikh KA, Djonovic M, Nedorubov AA, Odintsova E, Ivanov AV, Romanovskaya-Romanko EA, Stukova MA, Isaev AA, Krasilnikov IV.
Vakhrusheva AV, et al. Among authors: frolova me.
Vaccines (Basel). 2022 Aug 10;10(8):1290. doi: 10.3390/vaccines10081290.
Vaccines (Basel). 2022.
PMID: 36016181
Free PMC article.
Item in Clipboard
Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2.
Krasilnikov IV, Kudriavtsev AV, Vakhrusheva AV, Frolova ME, Ivanov AV, Stukova MA, Romanovskaya-Romanko EA, Vasilyev KA, Mushenkova NV, Isaev AA.
Krasilnikov IV, et al. Among authors: frolova me.
Vaccines (Basel). 2022 Jan 2;10(1):69. doi: 10.3390/vaccines10010069.
Vaccines (Basel). 2022.
PMID: 35062730
Free PMC article.
Item in Clipboard
Cite
Cite